A Trial of Neurocognitive and Supportive Therapy Interventions for Individuals With Parkinson's Disease
NCT ID: NCT01646333
Last Updated: 2016-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2012-07-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Results from this study will determine whether memory and problem solving therapies and supportive therapy are easily used by and beneficial for individuals with Parkinson's Disease and Mild Cognitive Impairment. If positive benefit is observed, information from this study will be used to further optimize these therapies for larger trials designed to evaluate the value of the therapies for individuals with Parkinson's Disease and their support persons.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Computer-based Cognitive Training for Individuals With Parkinson's Disease
NCT02225314
Rehabilitation of Everyday Memory Impairment in Parkinson Disease: A Pilot Study
NCT01469741
Prospective Memory Training in Parkinson Disease
NCT03582670
Everyday Memory Impairment in PD-related Cognitive Decline
NCT04474379
Piloting a Novel, Mobile Cognitive Tracking and Training Tool for Patients With Parkinson's Disease (PD)
NCT02922530
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Supportive Therapy
The supportive therapy offers patients and support persons the opportunity to discuss and reflect upon both Parkinson's Disease and non-Parkinson's Disease related problems.
Supportive Therapy
8 weekly 1 hour sessions of non-directive supportive therapy.
Memory and Problem-Solving Intervention
The memory and problem solving training consists of a day calendar manual and note taking system and problem solving techniques. The neurocognitive memory intervention was adapted from a 6-week manualized day calendar and note taking system previously evaluated in an amnestic MCI sample and a brain tumor sample. The problem solving intervention was adapted from an originally 12-week intervention, which was later adapted into a 6-week brain tumor sample.
Memory and Problem-Solving Intervention
8 weekly 1 hour sessions of memory compensation and problem-solving strategies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Memory and Problem-Solving Intervention
8 weekly 1 hour sessions of memory compensation and problem-solving strategies
Supportive Therapy
8 weekly 1 hour sessions of non-directive supportive therapy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical diagnosis of Mild Cognitive Impairment
Exclusion Criteria
* Clinical diagnosis of other Parkinson's Disease-associated comorbid conditions (e.g., severe anxiety, depression, excessive daytime sleepiness, or psychosis) that significantly influence cognitive testing
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Michael J. Fox Foundation for Parkinson's Research
OTHER
Virginia Commonwealth University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah K Lageman, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Virginia Commonwealth University
James P Bennett, Jr., M.D., Ph.D.
Role: STUDY_CHAIR
Virginia Commonwealth University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VCU Parkinson's and Movement Disorders Center
Richmond, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PT107964
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.